Sotatercept for the treatment of pulmonary arterial hypertension: a meta-analysis of randomized controlled trials

Sotatercept for the treatment of pulmonary arterial hypertension: a meta-analysis of randomized controlled trials

Saved in:
Bibliographic Details
Published in:European heart journal open Vol. 3; no. 5; p. oead086
Main Authors: Jaiswal, Vikash, Ang, Song Peng, Agrawal, Vibhor, Borra, Vamsikalyan, Bandyopadhyay, Dhrubajyoti, Dhakal, Aayusha, DeMarco, Teresa, Fonarow, Gregg C
Format: Journal Article
Language:English
Published: US Oxford University Press 01-09-2023
Subjects:
Analysis
Care and treatment
Diagnosis
Drug therapy
Medical research
Medicine, Experimental
Pulmonary hypertension
Research Letter
Transforming growth factors
United States
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Teresa DeMarco and Gregg C Fonarow contributed equally to this work.
Conflict of interest: G.C.F. has consulted for Abbott, Amgen, AstraZeneca, Bayer, BoehingerIngelheim, Cytokinetics, Eli Lilly, Johnson & Johnson, Medtronic, Merck, Novartis, and Pfizer. T.D.M. has disclosed Acceleron and CareDX research funding, Data, safety and monitoring committee for Merck/Acceleron.
ISSN:2752-4191
2752-4191
DOI:10.1093/ehjopen/oead086